Correlation Between Takeda Pharmaceutical and HSBC Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and HSBC Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and HSBC Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical and HSBC Holdings plc, you can compare the effects of market volatilities on Takeda Pharmaceutical and HSBC Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of HSBC Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and HSBC Holdings.

Diversification Opportunities for Takeda Pharmaceutical and HSBC Holdings

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Takeda and HSBC is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and HSBC Holdings plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HSBC Holdings plc and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with HSBC Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HSBC Holdings plc has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and HSBC Holdings go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and HSBC Holdings

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to generate 5.88 times less return on investment than HSBC Holdings. But when comparing it to its historical volatility, Takeda Pharmaceutical is 1.62 times less risky than HSBC Holdings. It trades about 0.05 of its potential returns per unit of risk. HSBC Holdings plc is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  845.00  in HSBC Holdings plc on September 1, 2024 and sell it today you would earn a total of  46.00  from holding HSBC Holdings plc or generate 5.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy91.3%
ValuesDaily Returns

Takeda Pharmaceutical  vs.  HSBC Holdings plc

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
HSBC Holdings plc 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HSBC Holdings plc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, HSBC Holdings may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Takeda Pharmaceutical and HSBC Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and HSBC Holdings

The main advantage of trading using opposite Takeda Pharmaceutical and HSBC Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, HSBC Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HSBC Holdings will offset losses from the drop in HSBC Holdings' long position.
The idea behind Takeda Pharmaceutical and HSBC Holdings plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Managers
Screen money managers from public funds and ETFs managed around the world